Sunshine Biopharma Inc (SBFM)

[TraderAI]

iluvcanada sniffed out this company 4-5 years ago. Outrun, thanks for posting this. Wonder if he is still around. A lot of the posts from 2018 show how SBFM has used the market as a washing machine since their inception. Don't need an 8-ball here to predict the future. SBFM had that 10-K blunder a couple years back which lit up Camille's phone due to accounting errors and other issues and had to issue an amended 10-K (10-K/A) to make their investors happy.

SBFM blundered their first attempt to uplist and gave up, and the second time, they did succeed, but look where we're at with this stock. They file for patents left and right and immediately PR them, along with FDA filings, and immediately tell the world "We've filed for FDA Fast tracking and Patent Priority" and never follow up with that. That's great, I'm going to PR the world that I mailed a letter or filed online and then put out a Press Release.

Anyone can literally file. SBFM-PL4 was exempt from fees with the FDA and patent office because it was marketed as a COVID treatment. No fees, no red tape, and then based the entire future of the company on filings that were never accepted, rejected, incomplete, etc, etc, with the intent to abandon these things all together because they didn't actually get the patents or FDA approvals. This is the stuff SBFM *NEVER* PR's. Only the fluff crap that they mailed a letter to the FDA and patent office and expect to cure pancreatic cancer as of the last power point.

adva-27a was labeled as a treatment for breast cancer, lung cancer, and other types of cancer (basically it just seems to kill everything). The latest powerpoint says it is now for pancreatic cancer.

SBFM-PL4 was stated as killing every variant of covid from Covid-19 to Covid-29. Really, wow! Yet they push vitamins and adva-27a that will expire before it ever gets to market, and if it did, it'll be a generic that anyone can copy. adva-27a is not marketable. If it was really worth a billion bucks, SBFM would have sold it to anyone willing to buy it. Instead, the only people interested were micro stock investors.

They're going to drop adva-27a and start the timelines all over with K1.1, which looks like it is some re-incarnated variant of adva-27a and SBFM-PL4:

"
Anticancer K1.1 mRNA
K1.1 is an mRNA that encodes an inhibitor of a transcription factor essential for initiation of cell division
We have recently shown that K1.1 mRNA is capable of destroying cancer cells in vitro including breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2)
Tests conducted using non-transformed (normal) cells (HMEC) showed that these K1.1 mRNA had little cytotoxic effects
K1.1 mRNA is readily adaptable for delivery into patients using the mRNA vaccine technology
In April 2022, we filed a provisional patent application in the United States covering the K1.1 mRNA molecules and uses thereof
Next, we plan to conduct mice xenograft studies to test the efficacy of K1.1 mRNA in vivo
"


It just never ends. I really wonder what the quarterly is going to say and project. Anyone who is still left is waiting on that before they get the hell out or the next pump before the next group of investors moves in and doesn't realize what a mess this company is.


Link to message: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140206966

From: iluvcanada
Re: Jagz16 post# 37528
Friday, April 20, 2018 4:29:07 PM
Post # 37529 of 111993

It's a pinky scam, just like so many others.....if you are even close to a profit or are even, SELL!!!! get the hell out of this garbage!

This isn't a company. It's a shell. It's a scam designed to make a few scumbags in Canada money. Not to mention, I can't verify or validate one thing they have ever accomplished. Not one. No drug license, no labs, no workers, no agreements, no valuation, no generics, and I'm pretty sure they mentioned in their last filing that ADVA-27a (which is not a real drug, nor will it ever be), was given to a company they started in Colorado (NOX Pharma). I doubt the purchase of Atlas ever took place. If it did, they used SBFM money to pay for it, and will privately benefit from it.

No shareholders will see any value added, just more dilution. Same thing happened with the purchase of the patents....investors paid for those, that money went directly to Advanomics, an address, not even a company that is owned by the same people. So we bought rights to Adva from this management teams personal business for millions, after Advanomics bought it from a French company for about 60K. SCAM.

Now it's reading like all that money investors used to buy the worthless patents is being given to a Colorado based company known as: NOX Pharma, which these morons own too. Not sure if it will one day be public, or maybe the gave the patents back to themselves for free, after raping SBFM investors.

https://www.sos.state.co.us/biz/BusinessEntityDetail.do?quitButtonDestination=BusinessEntityResults&nameTyp=ENT&masterFileId=20181234726&entityId2=20181234726&fileId=20181234726&srchTyp=ENTITY

https://www.sos.state.co.us/biz/ViewImage.do?masterFileId=20181234726&fileId=20181234726

I can go on and on and on......it's just another penny scam. That's the theme here. These guys just go further than most, to scam you out of your money.

If none of that convinces anyone, just read their last quarterly, it's beyond pathetic. Expect a bankruptcy filing soon, lay SBFM to rest, and start over with: NOX Pharma....... Why else start a new company and give it Adva-27a?

--
link: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139299109

From: iluvcanada
Re: None
Wednesday, March 14, 2018 9:45:45 PM
Post # 37506 of 111993

Anyone heard from(Camille) lately? Anyone tried calling or emailing? Or are we still running on their "word" on things?

This is why no one believes anything will happen this year. Or ever....
In November 2014, we entered into a Manufacturing Services Agreement with Lonza Ltd. and Lonza Sales Ltd. (hereinafter jointly referred to as “Lonza”), whereby we engaged Lonza to be the manufacturer of our Adva-27a anticancer drug. In June 2015 we received a sample of the pilot manufacturing run for evaluation. Our laboratory analyses showed that, while the sample meets the required biological specifications, the amount of material generated (the “Yield”) by the pilot run was found to be significantly lower than planned. During the course of our discussions concerning the problem of the low Yield, Lonza informed us that they required us to pay them $687,818 prior to moving forward with any activity pertaining to the manufacturing agreement we have with them. We have repeatedly indicated to Lonza that a clear path defining exactly how the extremely low Yield issue would be addressed is imperative prior to us making any payments. As of the date of this report, neither party has changed its position. See “Part I, Item 3 – Legal Proceedings.”

Keeping in mind, none of that is verifiable. Lonza won't comment, no one knows if any of that actually happened. That is a huge amount of money they are requesting. These idiots don't have that. They could have used the money they stole from investors for the patents they sold to themselves to fund this, but no one knows where that patent money went. If this was a billion dollar drug (Adva-27a), or you had actual leadership that believed in the drug, they would spend every cent they had to get it to market. There is no drug, there is no plan. SBFM is their own personal bank, nothing more. At this point, I'd accept them diluting this stock to fund another batch of the drug, at least it shows initiative and belief in the product. According to these scam artists, it's so much better than what's currently out there....why not dilute the stock to fund a new batch, rather than buy Atlas Pharma?